Shattuck Labs, Inc. (NasdaqGS: STTK)
Health Care · Biotechnology · US
$6.09
+2.01% today · +224.5% 1Y
Shattuck Labs, Inc. (NasdaqGS: STTK) operates in the Biotechnology industry within the Health Care sector. The company is valued at $599.17M and employs 40 people.
Over the last twelve months the share price has gained 224.5%, trading between 1.70 and 8.33.
Tweenvest scores Shattuck Labs, Inc. across four factors: quality 35/100, value 69/100, growth 51/100. Its strongest factor is value.
STTK price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $599.17M
- Revenue (TTM)
- $1.00M
- P/E
- —
- EPS
- -0.50
- Dividend yield
- —
- Beta (5Y)
- 1.10
- 52-week high
- $8.33
- 52-week low
- $1.70
- Avg volume (3M)
- —
- Shares outstanding
- 100.36M
- Employees
- 40
- Next earnings
- —
About Shattuck Labs, Inc.
Shattuck Labs, Inc. operates as a biotechnology firm based in the United States, currently at the clinical development stage. Its core mission is to create innovative therapeutics designed to combat both cancer and autoimmune diseases. The company's leading experimental compound, SL-172154, is presently undergoing Phase 1 clinical assessment for the treatment of ovarian, fallopian tube, and peritoneal cancers. Furthermore, Shattuck Labs is advancing another product candidate, SL-279252, which is also in Phase 1 trials for patients afflicted with advanced solid tumors and lymphoma. Established in 2016, the company maintains its corporate headquarters in Austin, Texas.
- ISIN
- US82024L1035
- Founded
- 2016
- Listed since
- Oct 9, 2020
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Sagimet Biosciences Inc.NasdaqGM: SGMT | $633.21M | $8.80 | -1.46% |
| Climb Bio, Inc.NasdaqGM: CLYM | $631.80M | $10.83 | -1.55% |
| Ironwood Pharmaceuticals, Inc.NasdaqGS: IRWD | $621.30M | $3.76 | -1.57% |
| Beijing Science Sun Pharmaceutical Co., Ltd.SZSE: 300485 | $616.28M | CN¥8.57 | -0.92% |
| Berry Genomics Co.,LtdSZSE: 000710 | $596.41M | CN¥11.30 | +3.96% |
| Silence Therapeutics plcNasdaqGM: SLN | $593.66M | $9.65 | -2.13% |
| Medicalsystem Biotechnology Co., LtdSZSE: 300439 | $591.56M | CN¥10.31 | +0.59% |
| Blau Farmacêutica S.A.BOVESPA: BLAU3 | $584.71M | R$12.61 | +16.54% |
Figures last refreshed Oct 11, 2026.